Quality improvement in cystectomy care with enhanced recovery (QUICCER) study

There is substantial genomic overlap between adeno-CRPCs and tNEPC. TMPRSS2-ERG is the most common genomic aberration in prostate cancer and has been reported in NEPC with a similar frequency [2]. Furthermore, both adeno-CRPCs and tNEPCs are enriched for the inactivation of key tumour suppressor genes, such as RB1 and TP53, compared with hormone-sensitive prostate cancer, albeit in different proportions [2]. Although genomic amplification and activating point mutations of the AR in tNEPCs are notably absent, the presence of AR-splicing variants, including ARv7, is still detectable, suggesting that AR signalling is still present in at least a proportion of tNEPCs [2].

[1]  E. Messing,et al.  Quality Improvement in Cystectomy Care with Enhanced Recovery (QUICCER) study , 2017, BJU international.

[2]  F. Burkhard,et al.  Intraoperative continuous norepinephrine infusion combined with restrictive deferred hydration significantly reduces the need for blood transfusion in patients undergoing open radical cystectomy: results of a prospective randomised trial. , 2014, European urology.

[3]  F. Burkhard,et al.  Restrictive Deferred Hydration Combined with Preemptive Norepinephrine Infusion during Radical Cystectomy Reduces Postoperative Complications and Hospitalization Time: A Randomized Clinical Trial , 2014, Anesthesiology.

[4]  Arturo Molina,et al.  Abiraterone and increased survival in metastatic prostate cancer. , 2011, The New England journal of medicine.

[5]  D. Gillatt,et al.  Introduction of an enhanced recovery protocol for radical cystectomy , 2008, BJU international.

[6]  D. Gouma,et al.  Systematic review of enhanced recovery programmes in colonic surgery. , 2006, The British journal of surgery.

[7]  A. Harris,et al.  REporting recommendations for tumour MARKer prognostic studies (REMARK) , 2005, British Journal of Cancer.

[8]  K. Lassen,et al.  Enhanced recovery after surgery: a consensus review of clinical care for patients undergoing colonic resection. , 2005, Clinical nutrition.

[9]  M. Rubin,et al.  Neuroendocrine expression in metastatic prostate cancer: evaluation of high throughput tissue microarrays to detect heterogeneous protein expression. , 2000, Human pathology.